NMPA issued a notice on the deferment of payment of registration review fees for drugs and medical device products (No. 81 of 2022) on September 29, 2022.
The main contents are as follows:
Registration applicants who submit applications for registration of drugs and medical devices products and are accepted during the October 1 to December 31, 2022, the registration fee is suspended for one quarter from the date it is due, without late payment fees.
Payment of review fees can be made by individuals using the payment code online transfer, but it needs to be handled in the bank that has opened the “non-tax payment” item.
Recently, because of the Covid-19, the average acceptance review time will be increased by 2 working days on top of the original 5 working days.
